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Abstract. The purpose of this experiment is to evaluate the influence of apitherapy 
diet on CCl4 induced hepatopathy in laboratory animals, by the means of leukocyte formula. 
The experiment was unfolded on six groups of Wistar rats: control group standard food 
(group I), control group apitherapy diet (group II), control group apitherapy diet + royal jelly 
(group III), CCl4 group (group IV), group CCl4 + apitherapy diet (group V), group CCl4 + 
apitherapy diet + royal jelly (group VI). The animals were handled under general anesthesia 
with thiopental. Hepatic lesion was induced by intraperitoneal injection of CCl4 (dissolved in 
paraffin oil, 10% solution). Hepatoprotection was achieved with apitherapy products 
(Apiregya, ApiImunomod, ApiImunostim, ApiImunostim Forte). Determination of the 
leukocyte formula was achieved by using an automatic analyzer and commercial kits. 
Administration of apitherapy diet and respectively of apitherapy diet and royal jelly in 
laboratory animals with CCl4 induced hepatopathy improves the values of parameters from 
the leukocyte formula when compared with CCl4 group. 
 




Liver damage may be provoked by various chemical substances, among which carbon 
tetrachloride (CCl4) stands for a vey well known experimental model of chemically induced 
hepatotoxicity (Stancey and Prietsly, 1978; Brattin et al., 1985; Rechnagel and Glene, 1973; 
Rikans et al, 1999; Kodavanti et al., 1989).  
Granulopoiesis takes place at the level of bone marrow and it is considered that 
neutrophilic, eosinophilic and basophilic granulocytes follow the same scheme of 
proliferation, differentiation, maturation and passage into bloodstream (Schubitz, 2004). 
  Leukocytes are divided into two main groups: granulocytes (neutrophils, eosinophils, 
basophils) and agranulocytes (lymphocytes and monocytes) (Carmel, 2004). 
Monocytes are the largest cells in the blood; they are part of the mononuclear 
phagocyte system/reticuloendothelial system composed of monocytes, macrophages and their 
bone marrow forerunners. The monocytes are released into the blood and, after a short 
circulation time, they migrate to different tissues, at random or in a specific manner, as a 
response to the various chemotactic factors.  Phylogenetically, the cells of the phagocyte 
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system are primitive cells, as no animal can live without them. They fulfill a large variety of 
functions, including the removal of foreign, senescent, dead or damaged cells, regulation of 
the function of other cells, processing of antigens in immune reactions, implication in 
different inflammatory processes, destruction of bacterial and tumor cells. Monocytes and 
macrophages produce numerous bioactive compounds: enzymes, complement factors, 
coagulation factors, oxygen reactive species, nitrogen, angiogenesis factors, binding proteins 
(transferrin, transcobalamin II, fibronectin, apolipoprotein E), bioactive lipids (derivatives of 
arachidonic acid), chemotactic factors, cytokines, growing factors (interferon - IFN α and γ, 
interleukins - IL 1,3,6,8,10,12, fibroblast growth factor - FGF, platelet-derived growth factor - 
PDGF, tumor necrosis factor - TNF, macrophage colony-stimulating factor – MCSF) 
(Perkins, 2004; Fischbach, 2004;  Weinberg, 2004). 
 
MATERIALS AND METHODS 
 
Hepatic lesion was induced by intraperitoneal injection of CCl4 (dissolved in paraffin 
oil, 10% solution). Two ml per 100 g were administered, once at 2 days, for 2 weeks. The 
experiment was unfolded on six groups of Wistar rats. The first group served as control, the 
second one was fed with apitherapy diet, the third group was given apitherapy diet and royal 
jelly. The next three groups of animals were intoxicated with CCl4 and fed with normal food 
(group IV), apitherapy diet (group V) and apitherapy diet with royal jelly (group VI). 
The laboratory animals were given food supplements produced by S.C. STUPINA S.R.L, 
Bălăneşti, Gorj, Romania, supplements represented by Apiregya, ApiImunomod, 
ApiImunostim, ApiImunostim Forte. The daily administered doses were 2g Apiregya,  1g 
ApiImunomod, 1g ApiImunostim, 1g ApiImunomod Forte. These preparates included in their 
composition: honey, royal jelly, propolis, and pollen. The preparates were registered to OSIM 
with number AO 1242. 
The animals were sacrificed by administration of thiopental, after three weeks of 
apitherapy treatment. After the laboratory animals were anesthesiated with thiopental (dose of 
1 ml/100 g from a 0.01% thiopental solution), blood samples were collected by the punction of 
the cord. The investigated parameters were: number of leukocytes, neutrophils, eosinophils, 
basophils, lymphocytes and monocytes.  The determination of the values of the investigated 
parameters were achieved with an automated analyzer (Aeroset, Abbott) and commercial kits 
(Abbott, USA). 
The statistical interpretation of the results was performed with One-Way ANOVA test 
and Tukey’s post-hoc test. The results were given as mean ± standard deviation. The value  of 
p<0.05 was considered significant. 
 
RESULTS AND DISCUSSIONS 
 
Number of leukocytes 
In animals with CCl4 induced hepatopathy (group IV) a statistically significant decrease 
of WBC can be noticed when compared to the following groups: i) control group apitherapy 
diet (group II) (10.781.62 versus 4.860.69, p<0.0001); ii) control group apitherapy diet + 
RJ (group III) (11.921.07 versus 4.860.69, p<0.0001) (fig. 1). 
Administration of apitherapy diet to laboratory animals with CCl4 induced hepatopathy 
(group V) determines the statistically significant increase of WBC when compared with: i) 
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control group standard food (group I) (5.871.62 versus 10.392.6, p=0.0004); ii) CCl4 group 
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Fig. 1. Mean values of WBC (10
3/μL) and standard deviation (* a p<0.05 vs. control group 
standard food; * b   p<0.0001 vs. control group apitherapy diet; * c   p<0.0001 control group 
apitherapy diet+RJ, * d  p<0.0001 vs. CCl4 group). 
 
Administration of apitherapy diet and royal jelly (RJ) to laboratory animals with CCl4 
induced hepatopathy (group VI) determines the statistically significant increase of the number 
of WBC in comparison with: i) control group standard food (group I) (5.871.62 versus 
11.491.01, p<0.0001); ii) CCl4 group (group IV) (4.860.69 versus 11.4911.49, p<0.0001) 
(fig. 1). 
Between groups V (group CCl4 + apitherapy diet) and VI (group CCl4 + apitherapy diet 
+ RJ) no statistically significant differences regarding WBC could be noticed (fig. 1).  
Number of neutrophils 
In animals with CCl4 induced hepatopathy (group IV) a statistically significant decrease 
of the number of neutrophils (10
3
/L) can be noticed when compared with the control group 
standard food (group I)  (1.790.25 versus 1,0090.13, p<0.0001). Administration of CCl4 
(group IV) determines a statistically significant increase of the number of neutrophils 
(10
3
/L) in comparison with control group apitherapy diet (group II) (0.7910,13 versus 
1,0090.13, p<0.0018) (fig. 2). 
Administration of apitherapy diet to laboratory animals with CCl4 induced hepatopathy 
(group V) determines a statistically significant decrease of the number of neutrophils (10
3
/L) 
when compared with: i) control group standard food (group I) (1.7910.25 versus 1.0840.36, 
p<0.0001); ii) control group apitherapy diet + RJ (group III) (1.490.03 versus  1.0840.36, 
p=0.0123) (fig. 2). 
Administration of apitherapy diet and RJ to laboratory animals with CCl4 induced 
hepatopathy (group VI) determines a statistically significant increase of the number of 
neutrophils (10
3
/L) in comparison with: i) control group apitherapy diet (group II) 
(0.7910.13 versus 1.3430.25, p=0.0003); ii) CCl4 group (group IV) (1.0090.13 versus  
1.3430.25, p<0.0001) (fig. 2). 
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No statistically significant differences regarding the number of neutrophils (10
3
/L) 
could be noticed between groups V (group CCl4 + apitherapy diet) and VI (group CCl4 + 
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Fig. 2. Mean values of neutrophils (10
3
/μL) and standard deviation (* a   p<0.0001 vs. control 
group standard food; * b   p<0.05 vs. control group apitherapy diet; * c   p=0.0123 vs. control 
group apitherapy diet+RJ; * d   p=0.0296 vs. CCl4 group). 
 
Number of lymphocytes 
In animals with CCl4 induced hepatopathy (group IV) a statistically significant decrease 
of the number of lymphocytes (10
3
/L) can be noticed when compared with the control group 
apitherapy diet+RJ (group III) (8.740.25 versus 3.640.55, p<0.0001) (fig. 3). 
Administration of apitherapy diet to laboratory animals with CCl4 induced hepatopathy 
(group V) determines a statistically significant increase of the number of lymphocytes 
(10
3
/L) when compared with: i) control group standard food (group I) (3.491.09 versus 
6.521.92, p<0.0001); ii) CCl4 group (group IV) (3.640.55 versus  6.521.92, p<0.0001) 
(fig. 3). Co-administration of CCl4 and apitherapy diet (group V) results in statistically 
significant decrease of the number of lymphocytes (10
3
/L) in comparison with control group 
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Fig. 3. Mean values of lymphocytes (10
3
/μL) and standard deviation (* a   p<0.0001 vs. 
control group standard food;; * b   p<0.0001 vs. control group apitherapy diet; * c   p<0.05 vs. 
control group apitherapy diet+RJ; * d   p<0.0001 vs. CCl4 group). 
 
Administration of apitherapy diet and RJ to laboratory animals with CCl4 induced 
hepatopathy (group VI) determines a statistically significant increase of  the number of 
lymphocytes (10
3
/L) when compared with: i) control group standard food (group I) 
(3.491.09 versus 8.171.24, p<0.0001); ii) control group apitherapy diet (group II) 
(5.270.65 versus 8.171.24, p<0.0001); iii) CCl4 group (group IV) (3.640.55 versus 
8.171.24, p<0.0001) (fig. 3). 
No statistically significant differences regarding the number of lymphocytes (10
3
/L) 
could be noticed between groups V (group CCl4 + apitherapy diet) and VI (group CCl4 + 
apitherapy diet + RJ) (fig. 3). 
Number of monocytes 
No statistically significant differences regarding the number of monocytes could be 
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Fig. 4. Mean values of the number of monocytes and standard deviation. 
 
Number of eosinophils 
In animals with CCl4 induced hepatopathy (group IV) a statistically significant decrease 
of the number of eosinophils can be noticed when compared with control group standard food 
(group I) (0.4310.11 versus 0.2850.09, p=0.01). In animals with CCl4 induced hepatopathy 
(group IV) a statistically significant increase of the number of eosinophils (10
3
/L) can be 
noticed when compared with control group apitherapy diet (group II) (0.1580.02 versus  
0.2850.09, p=0.037) (fig. 5). 
Administration of apitherapy diet to laboratory animals with CCl4 induced hepatopathy 
(group V) determines a statistically significant decrease of the number of eosinophils (10
3
/L) 
when compared with control group standard food (group I) (0.4310.11 versus 0.2360.1, 
p<0.0003) (fig. 5). 
Administration of apitherapy diet and RJ to laboratory animals with CCl4 induced 
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Control group apitherapy diet+RJ CCl4 group
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Fig. 5. Mean values of eosinophils (10
3
/μL) and standard deviation (* a   p<0.05 vs. control 
group standard food; * b   p<0.05 vs. control group apitherapy diet). 
 
Administration of apitherapy diet and RJ to laboratory animals with CCl4 induced 
hepatopathy (group VI) results in a statistically significant increase of the number of 
eosinophils (10
3
/L) when compared with control group apitherapy diet (group II) (0.158 
0.02 versus 0.2550.07, p<0.0289) (fig. 5). 
No statistically significant differences regarding eosinophils could be noticed between 
groups V (group CCl4 + apitherapy diet) and VI (group CCl4 + apitherapy diet + RJ) (fig. 5). 
Number of basophils 
No statistically significant differences regarding the basophils can be noticed for the 
experimental groups, except for the group that received only CCl4, where a marked decrease 
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Fig. 6. Mean values of the number of basophils and standard deviation. 
 
The most numerous type of leukocytes (neutrophils) plays a major role in primary anti-
infectious defence of the organism by phagocytosis and digestion of microorganisms. Their 
inappropriate activation may lead to the lesion of normal tissues by releasing enzymes and 
pyogenic agents (Schubitz, 2004). 
The increase of neutrophils takes place, among other causes, due to the toxic 
substances and certain drugs. Neutriphilia can be also caused by infections, inflammatory, 
metabolic and mieloproliferative disorders, tissue necrosis, acute hemorrhagia, malignant 
tumors (DeMott and Tilzer, 1994; Thomas and Bartl, 1998). 
In the blood of healthy subjects, eosinophils are found in small amounts but become 
prevalent in blood and tissues in the conditions of different allergic, parasitary or malignant 
diseases (Fischbach, 2004; Skubitz K, 2004). 
Few mastocyte populations answer to some neuropeptids, and the tight anatomical 
association between mastocytes and nerves represent the evidence of the neurogenic component 
dependent on the allergic reactions mastocytes (Befus et al, 2004). 
Monocytosis appears in hepatic cirrhosis, parasitary and gastrointestinal diseases, collagen 
disorders, post-surgery and other conditions (Weinberg, 2004). 
The decrease of the basophilic population can be remarked after the administration of CCl4. 
The diminution of the basophils values are also met after administration of procainamide and 
thiopental (Fischbach, 2004). 
Basophils and mastocytes are two types of leukocyte populations that have many 
similarities but also some differences. The presence of the mastocyte forerunners in blood is met 
in liver and kidney chronic diseases, asthma, anaphylactic shock, macroglobulinemia, lymphoma 
with medullary invasion, suprarenal insufficiency, osteoporosis (DeMott and Tilzer, 1994; 
Thomas and Bartl, 1998). In the present experiment, a marked decrease of basophils after the 
administration of CCl4 can be noticed.  
In this study, the protective role of apitherapy products on the leukocyte formula in 
experimentally CCl4-induced hepatotoxicity in rats has been evaluated. The results of our 
study suggest that the pretreatment with apitherapy products plays a protective role in 
coagulation disorders associated with CCl4 administration in rats.  
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Administration of standard food causes a significant increase of the number of 
neutrophils, while administration of CCl4 determines the decrease of neutrophils.  
Administration of standard food (group I) and CCl4 (group IV) determines a significant 
decrease of the number of lymphocytes, while administration of apitherapy diet and RJ  
determines the increase of lymphocyte values, both in the control group and the group that 
was given CCl4. Administration of apitherapy diet to the animals from the control group 
standard food and CCl4 group leads to a mean value of lymphocytes. Administration of 
standard food leads to an increase of the eosinophilic values, increase that is more advanced 
when compared to increase produced by administration of CCl4. Administration of apitherapy 
diet and respectively of  apitherapy diet and RJ to the groups that had been previously given 
CCl4 leads to a value of eosinophils comparable to the control groups.  Administration of 
standard food produces the decrease of the leukocyte number, while the apitherapy diet and 
respectively, the apitherapy diet and RJ given to the control healthy groups results in the 
increase of the leukocyte values. Administration of apitherapy diet and respectively, of 
apitherapy diet and RJ leads to an increase of the leukocyte values for the groups that had 
been previously given CCl4. 
There are also studies regarding other natural products with hepatoprotective effect in 
experimentally CCl4 induced hepatopathy: Saccharomyces cerevisiae (Lai et al., 2009); 
lycopene from tomatoes (Kim et al., 2004); dehydrocavidine, an active compound from 
Corydalis saxicola Bunting (Yanhuanglian) (Wang et al., 2008); The diterpenes cafestol and 
kahweol from coffee (Lee et al., 2007); electrolyzed water (Tsai et al., 2009); the flavone 
luteolin (3′,4′,5,7-tetrahydroxyflavone) (Domitrović et al., 2009); hyaluronic acid and 
chondroitin-4-sulfate (Campo et al, 2004); olive oil (Fang et al., 2008); potato skin extract 




Administration of apitherapy products leads to the improvement of the leukocyte 
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